Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion

Istvan Bodi1, David Gonzalez, Prasanna Epaliyange

  • 1Department of Clinical Neuropathology, King's College Hospital, London, UK. Istvan.Bodi@kch.nhs.uk

Insights

This rare case highlights alveolar soft part sarcoma (ASPS) presenting as a brain tumor. Molecular analysis confirmed ASPS, a sarcoma subtype, without an obvious primary tumor site.

Area of Science:

  • Oncology
  • Neuropathology
  • Rare Cancers

Background:

  • Metastatic sarcoma to the brain is infrequent, and seldom the initial presentation.
  • Alveolar soft part sarcoma (ASPS) is a rare but documented sarcoma subtype.

Observation:

  • A 39-year-old male presented with seizures due to a left temporal meningeal lesion with significant brain edema on MRI.
  • Histopathological examination revealed large tumor cells with pseudoalveolar patterns and rare cytoplasmic inclusions.
  • Immunohistochemistry showed positivity for vimentin and smooth muscle actin, suggesting ASPS.

Findings:

  • Molecular analysis, including RT-PCR and sequencing, identified an ASPSCR1-TFE3 fusion, confirming the ASPS diagnosis.
  • No primary extracranial tumor was detected via physical examination or CT scans 11 months post-presentation.
  • The findings suggest a potential primary meningeal ASPS, though metastasis from an occult primary site remains a possibility.

Implications:

  • This case expands the known clinical presentations of ASPS, particularly its occurrence in the meninges.
  • It underscores the importance of molecular diagnostics in confirming rare tumor diagnoses.
  • Further research is needed to understand the origins and behavior of meningeal ASPS.